Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part III
In part three of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores China’s efforts to increase its market share of artemisinin-based combination therapies worldwide. “…To sum up, China has come a long way in developing and promoting its own artemisinin-based products, but there is still a long way to go before it is able to seriously challenge the status quo in the international anti-malarial market” (3/11).